| Announce Date | 11/13/2025 |
| EPS Normalized Actual | $-0.28 (Beat by $0.35) |
| EPS GAAP Actual | $-0.28 (Beat by $0.35) |
| Revenue Actual | $0.019021B |
| Revenue Surprise | Beat by $19.021M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $-0.6 |
| EPS GAAP Estimate | $-0.6 |
| Revenue Estimate | $0.027375B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Dec 2026 | -0.65 | -1.11 | -0.69126 | -0.617 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.28 | 0.68 | 0.019021B | -37.95% | -2.73M |
| FQ2 2025 (Jun 2025) | -0.63 | -0.55 | 0.019462B | -43.79% | -2.29M |
| FQ1 2017 (Mar 2017) | -2.79 | -2.79 | 0.005322B | 100% | 5.32M |
| FQ2 2017 (Jun 2017) | -2.71 | -2.71 | 0.005631B | 100% | 5.63M |
| FQ3 2017 (Sep 2017) | -4.55 | -4.55 | 0.012392B | 100% | 12.39M |
| FQ4 2017 (Dec 2017) | -5.26 | -5.26 | 0.013114B | 100% | 13.11M |
| FQ1 2025 (Mar 2025) | -0.52 | -0.44 | 0.01536B | -31.6% | -4.83M |
| FQ4 2024 (Dec 2024) | -0.18 | 0.28333 | 0.024607B | -33.11% | -0.28M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.6
Consensus Revenue Estimates
0.027375B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Dec 2026) | -0.38 | -- | -0.38802 | -0.36947 | 1 |
| FQ3 2026 (Sep 2026) | -0.3 | 6.67 | -0.30633 | -0.29168 | 1 |
| FQ2 2026 (Jun 2026) | -0.26 | -142.31 | -0.26548 | -0.25279 | 1 |
| FQ1 2026 (Mar 2026) | -0.64 | 18.75 | -0.6535 | -0.62226 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ3 2027 (Sep 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ2 2027 (Jun 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ1 2027 (Mar 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ3 2026 (Sep 2026) | 0.03B | 37.39 | 0.03B | 0.03B | 1 |
| FQ2 2026 (Jun 2026) | 0.03B | 36.04 | 0.03B | 0.03B | 1 |
| FQ1 2026 (Mar 2026) | 0.02B | 27.13 | 0.02B | 0.02B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.96 | -0.28 | 0.68 | -242.86% |
| FQ2 2025 (Jun 2025) | -0.08 | -0.63 | -0.55 | 87.3% |
| FQ1 2017 (Mar 2017) | -2.79 | -2.79 | 100% | |
| FQ2 2017 (Jun 2017) | -2.71 | -2.71 | 100% | |
| FQ3 2017 (Sep 2017) | -4.55 | -4.55 | 100% | |
| FQ4 2017 (Dec 2017) | -5.26 | -5.26 | 100% | |
| FQ1 2025 (Mar 2025) | -0.08 | -0.52 | -0.44 | 84.62% |
| FQ4 2024 (Dec 2024) | -0.46333 | -0.18 | 0.28333 | -157.41% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.02B | $0.02B | $-2.73M | -14.37% |
| FQ2 2025 (Jun 2025) | $0.02B | $0.02B | $-2.29M | -11.78% |
| FQ1 2017 (Mar 2017) | $0B | $0.01B | $5.32M | 100% |
| FQ2 2017 (Jun 2017) | $0B | $0.01B | $5.63M | 100% |
| FQ3 2017 (Sep 2017) | $0B | $0.01B | $12.39M | 100% |
| FQ4 2017 (Dec 2017) | $0B | $0.01B | $13.11M | 100% |
| FQ1 2025 (Mar 2025) | $0.02B | $0.02B | $-4.83M | -31.47% |
| FQ4 2024 (Dec 2024) | $0.02B | $0.02B | $-0.28M | -1.12% |